Venous ulcers are a big market... and time will tell
What can be said is that Re-cell in its various formats has been around for a lot longer than TIS, and is better established in trials (although for those of us who remember Clinical Cell culture, those trials were a long time coming).
- Forums
- ASX - By Stock
- TIS
- TIS Vs Avita Medical
TIS Vs Avita Medical, page-5
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online